Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Sprout Health vs Genesis Lifestyle Medicine

Two GLP-1 desks, one scoreboard. We put Sprout Health and Genesis Lifestyle Medicine head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 6 · Grade B

Sprout Health

Visit Sprout Health Full brief →
vs
No. 422 · Grade C

Genesis Lifestyle Medicine

Visit Genesis Lifestyle Medicine Full brief →

The verdict

Sprout Health takes this head-to-head.

Sprout Health scores 86 to 53 on our six-factor Brief Score — A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.

That doesn't make Genesis Lifestyle Medicine a bad call — it's best for readers who want hybrid med-spa glp-1 with 18 clinics and brand-name access. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
90
40
Supply Reliability
82
74
Transparency
88
23
Access Breadth
92
42
Clinical Oversight
78
78
Track Record
84
70
Sprout HealthBrief Score 86 · 53Genesis Lifestyle Medicine

Price, coverage & the tracker

Sprout HealthGenesis Lifestyle Medicine
Brief Score86/100 (B)53/100 (C)
Semaglutide$149/moNot disclosed
Tirzepatide$199/moNot disclosed
CoverageNot disclosed8 states
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

Sprout Health: Compounded $149 semaglutide / $199 tirzepatide held flat this cycle, with a brand-name Wegovy/Zepbound path available on the same account.

Genesis Lifestyle Medicine: New to the tracker on 1 August 2026. This program publishes no monthly medication price, so there is no line for us to track until it does.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.